Thursday, September 28, 2017

Scythian Biosciences Corp. (TSXV: $SCYB.V) Forms Professional Athlete Advisory Committee

www.investorideas.com - News that inspires big Ideas

TORONTO - September 28, 2017 (Investorideas.com Newswire) Scythian Biosciences Corp. (the "Company") (TSXV: SCYB) is pleased to announce the formation of its Professional Athlete Advisory Committee. The purpose of this committee is to bring together various, current, and former pro-athletes who have experienced or share concern for the pain and suffering associated with concussions that occur during sports competitions.
"The member's intimate knowledge and personal experience will lend Scythian and our research partners at the University of Miami great insight into the world of sports and the aftermath of head injuries. Bart Oates, who has been an Advisory Board member will head up this committee and lead in recruiting new inductees from Professional Football, Hockey, Basketball, Boxing, Soccer and more," commented Mr. Jonathan Gilbert, CEO of the Company.

http://www.investorideas.com/CO/SCYB/news/2017/09281ProfessionalAthlete.asp

Tuesday, September 26, 2017

SinglePoint (OTC: $SING) Finalizes Letter of Intent to Acquire 51% of Denver-Based Company approaching $1 Million in Annual Revenue

www.investorideas.com - News that inspires big Ideas

SEATTLE, WA - September 26, 2017 (Investorideas.com Newswire) SinglePoint, Inc. (OTC:SING), a holding company specialized in the acquisition of small to mid-sized companies with an emphasis on new technologies, today announces that it has signed a Letter of Intent ("LOI") to acquire a Denver, Colorado-based company that is approaching $1 million in annual revenue. According to the LOI, SinglePoint will acquire 51 percent of the acquisition target in a stock and cash transaction expected to increase shareholder and company value, and deliver to SinglePoint immediate revenues with a healthy margin.
Year-to-date SinglePoint has acquired or invested in three companies resulting in revenue growth and solidifying the Company's revenue-by-acquisition model. This agreement is yet another demonstration of SinglePoint's ability to strategically grow its portfolio of investments in established, high-potential companies.
SinglePoint CEO Greg Lambrecht states, "We are committed to identifying and making investments in companies that strengthen SinglePoint's value. Our goal is to find and acquire companies we believe will add instant value as well as the opportunity for major growth."
SinglePoint plans to close this opportunity within the coming weeks. The company has additional acquisition targets that are in negotiation and will continue to pursue revenue-generating companies that are in alignment with SinglePoint's goals.
In addition to this LOI, SinglePoint is nearing its completion of 2016 audited financials. Upon completion SinglePoint will apply to up-list to the OTCQB. Management expects to have this audit completed in 2018


Disclosure: SinglePoint, Inc. (OTC: $SING) is featured on the 420 Cannabis Investor Ideas of 2017 at www.420cannabisinvestorideas.com
SinglePoint, Inc. (OTC: SING) is a featured company on Investorideas.com
View the profile on Investorideas.com

Disclaimer: This directory is not a recommendation to buy or sell securities or products or services Investorideas.com charges a fee for placement. The directory is not an endorsement or recommendation but meant to be an investor resource/ due diligence tool.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. Disclosure: Companies Featured on the 420 Cannabis Investor Ideas have paid a one-time fee of Up to $1000 to be featured on the directory and SING is also a paid featured cannabis and bitcoin company for news and PR social media
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

http://www.investorideas.com/CO/SING/news/2017/09261Acquire.asp


Monday, September 25, 2017

Pershing Gold (NASDAQ: $PGLC) (TSX: $PGLC.TO) to Present at 2017 Denver Gold Forum

Pershing Gold (NASDAQ: $PGLC) (TSX: $PGLC.TO) to Present at 2017 Denver Gold Forum



LAKEWOOD, Colo. - September 25, 2017 (Investorideas.com Newswire) Pershing Gold Corporation (NASDAQ:PGLC) (TSX:PGLC) (FWB:7PG1) ("Pershing Gold" or the "Company"), an emerging Nevada gold producer, announces that Stephen Alfers ("Alfers"), Pershing Gold's Executive Chairman, CEO and President, will present at the 2017 Denver Gold Forum in Colorado Springs, Colorado.
The Denver Gold Forum is being held September 25-27, 2017, at the Broadmoor in Colorado Springs, CO. Alfers will be presenting at 1:45pm on Tuesday, September 26.
Alfers will provide a Company update during the live presentation and participate in one-on-one meetings with registered conference investors. Registration is by invitation only to qualified investors, portfolio managers, and private wealth managers.
A webcast of the presentation will be available on September 29, 2017:
http://www.denvergoldforum.org/xpl17/company-webcast/PGLC:US/
About Pershing Gold Corporation
Pershing Gold is an emerging gold producer whose primary asset is the Relief Canyon Mine in Pershing County, Nevada. Relief Canyon includes three historic open-pit mines and a state-of-the-art, fully permitted and constructed heap-leach processing facility. Pershing Gold is currently permitted to resume mining at Relief Canyon under the existing Plan of Operations.
Pershing Gold's landholdings cover approximately 25,000 acres that include the Relief Canyon Mine asset and lands surrounding the mine in all directions. This land package provides Pershing Gold with the opportunity to expand the Relief Canyon Mine deposit and to explore and make new discoveries on nearby lands.
Pershing Gold is listed on the NASDAQ Global Market and the Toronto Stock Exchange under the symbol PGLC and on the Frankfurt Stock Exchange under the symbol 7PG1.
View original content with multimedia:http://www.prnewswire.com/news-releases/pershing-gold-to-present-at-2017-denver-gold-forum-300525183.html
SOURCE: Pershing Gold Corporation
View original content with multimedia: http://www.newswire.ca/en/releases/archive/September2017/18/c4883.html
Contact Information
For more information, please contact:
Stephen Alfers, Executive Chairman, President and CEO
Jack Perkins, Vice President, Investor Relations
720.974.7254
investors@pershinggold.com
www.PershingGold.com

Pershing Gold Corporation (NASDAQ: PGLC) (TSX:PGLC)

is a Featured mining company on Investorideas.com
Visit Profile page: http://www.investorideas.com/CO/PGLC/
Get News Alerts on Pershing Gold Corporation
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp Disclosure: Pershing Gold Corporation (NASDAQ: PGLC) (TSX: PGLC) is a paid PR, media and news client effective June 2017 for 2 months

Gold Mining Stocks - Gold Mining Stocks Directory, Gold Stocks News, Research and Resources

Gold-MiningStocks.com - investing ideas in gold and mining stocks

Like Gold Stocks? View our Gold / Mining Stocks Directory

Get News on Mining Stocks

#Tech News: Gopher (OTCQB: $GOPH) Proudly Introduces its New CEO

#Tech News: Gopher (OTCQB: $GOPH) Proudly Introduces its New CEO

Gopher Protocol Inc. (OTC:GOPH)

SAN DIEGO, CA - September 25, 2017 (Investorideas.com Newswire) Gopher Protocol Inc. (OTCQB: GOPH) ("Gopher" or the "Company"), a development-stage company which specializes in the creation of Internet of Things (IoT), Artificial Intelligence enabled mobile technologies and distribution is proud to introduce its new CEO to shareholders and followers, in a personal letter from Gregory Bauer:
I wanted to take this opportunity to introduce myself as the new CEO of Gopher Protocol, as well as a fellow shareholder.
I have joined Gopher Protocol as part of Gopher's recent acquisition of UGO HUB assets.
We are going to be using the UGO HUB assets to create a "store within a store" offering several prepaid and cellular services as well as launching our branded UGO accessory product line for consumers. The assets we acquired provide us with basic infrastructure within 15,000 convenience stores located across the United States with a "heavy presence" in the south east to empower a Gopher network for future product releases.
Before we go into the strategy of the acquisition -- I will describe the parts of my background and experience that I believe will help me to succeed as CEO of Gopher Protocol.
My background includes working in technology and product distribution companies. Most recently growing a distribution division to over $140 million in revenue. In addition, I have had previous successful exits selling companies to large corporations and in the technology information space. I also have experience running public companies, so I am familiar with the requirements.
Based on my experience, I am excited about the opportunities I see in Gopher Protocol to expand the existing technology and take it to market. Let me start by describing the current operations of the assets recently acquired.
The recent Gopher acquisition will be generating revenues as a retail partner of the major telecoms through the distribution of financial products as well as cellular "top-off" cards. We believe this acquisition is a game changer for Gopher with the goal of placing Gopher on the path to a cash flow positive company. In addition, our goal is to provide the Company with more flexibility in developing and deploying its technology portfolio and to take advantage of the disruptive products developed by our CTO Danny Rittman.
Allowing that the acquisition makes sense from a financial standpoint, the beauty of having 15,000 points of presence across the United States will allow us to distribute our internal inventions in those locations, in the future.
Finally, and perhaps most importantly, it is our goal to deploy connected devices into those locations to create the radio frequency network that we described in our recent video -- https://youtu.be/9ovYCMHmOi8. This will create the access points to the internet needed by our connected devices which will allow them to connect to the internet with no monthly fees.
To summarize our recent moves:
New CEO with public company experience, investor exits, and building large companies.
15,000 distribution points for our soon to be launched products with access to an estimated 30,000,000* customers weekly. (*http://distributech.net//Demographics.aspx)
I look forward to building shareholder value as we execute on the ambitious plans we have for the future.
Best regards,
Gregory Bauer
About UGO HUB
UGO HUB products include: prepaid financial services (credit card, phone card, gift card, etc.), financial services - bill pay, ATM, payday loans, check cashing, Bitcoin, etc.), products and accessories - SIM Card, cell phone, as well as novelties, such as electronic accessories. UGO HUB operates on a leased space and revenue sharing arrangement with partner locations instead of a traditional wholesaling model.
About Gopher Protocol Inc.
Gopher Protocol Inc. (OTCQB: GOPH) ("Gopher" and the "Company") (http://gopherprotocol.com/) is a development-stage company which consider itself Native IoT creator, developing Internet of Things (IoT) and Artificial Intelligence enabled mobile technology. The Company has a portfolio of Intellectual Property that when commercialized will include smart microchips, mobile application software and supporting cloud software. The system contemplates the creation of a global network. The core of the system will be its advanced microchip technology that can be installed in any mobile device worldwide. Gopher envisions this system as an internal, private network between all enabled mobile devices providing shared processing, advanced mobile database management/sharing and enhanced mobile features.
Corporate Site: http://gopherprotocol.com
Press page/ press kit - http://gopherprotocol.com/?page_id=228
Consumer and product website for Guardian Patch: http://www.guardianpatch.com/.
About Guardian Pet Tracker www.guardianpettracker.com
The Guardian Pet Tracker (Sphere Internal name -- the "Sphere") system is a derivative technology of Gopher's Guardian Patch technology. The Sphere is designed to provide its users with local tracking capability using a re-chargeable/replaceable battery source. Gopher intends to release pre-production units in limited test in the near future.
GOPH disclosure: More info: SEC link /technology abstract:
Forward-Looking Statements
Certain statements contained in this press release may constitute "forward-looking statements". Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website (http://www.sec.gov). In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, and governmental and public policy changes. The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of the press release.
Contact:
Greg Bauer CEO
Gopher Protocol Inc.
VM Only 888-685-7336
Media: press@gopherprotocol.com

Gopher Protocol, Inc. (OTCQB:GOPH) is a featured tech stock on Investorideas.com

Visit profile page
Get News Alerts on Gopher Protocol, Inc.

Disclaimer/Disclosure:
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure: GOPH is a PR , social media and publishing client and compensates Investorideas.com (effective April 4, 2016 - three thousand five hundred per month )More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

CTO of Scythian Biosciences Corp. (TSXV: $SCYB.V) Talks about Drug Development and Commercialization and Potential of #Cannabinoids

CTO of Scythian Biosciences Corp. (TSXV: $SCYB.V) Talks about Drug Development and Commercialization and Potential of #Cannabinoids

Former VP of Celgene (NASDAQ: $CELG) Talks about Scythian’s Potential Treatment for Concussion and/or TBI

September 25, 2017 – Investorideas.com, a global news source and investor resource covering cannabis and biotech stocks releases an exclusive Q&A  interview with  Maghsoud Dariani, CTO of Scythian Biosciences Corp. (TSXV: SCYB).

Scythian Biosciences Corp. (TSXV: SCYB) reported September 13th that Maghsoud Dariani has become the Chief Scientific Officer of the Company. Mr. Dariani was previously on the Company's advisory board and has over 35 years of experience in the development and commercialization of products in the pharmaceutical industry. Mr. Dariani's experience includes, among other things, management positions at Semorex, Focus Pharmaceuticals, Celgene (NASDAQ: CELG) and Chiral Pharmaceuticals.

Q&A Interview:

Q: Investorideas.com
Congratulations on your recent appointment as Chief Scientific Officer of Scythian Biosciences. Can you talk about your new role and based on the current stage of development of the company’s drug treatment for concussions and traumatic brain injury with its proprietary Cannabinoid combination, what you see as the next steps?

A: Maghsoud Dariani, Chief Scientific Officer
Thank you! I am excited to join Scythian Biosciences and look forward to working with the team to manage the development of our proprietary Cannabinoid combination drug for the treatment of concussion and traumatic brain injury (TBI).  We are extremely fortunate to be collaborating with the University of Miami, a premier research center on concussion and TBI to develop an effective drug treatment for this disorder. TBI, which can result in long-term negative and life altering symptoms affects more than 2 million; mostly young people in the US alone and there is no standard drug treatment, making this a significant unmet need. 

We are currently conducting pre-clinical studies in accepted rodent models to establish the efficacy of our combination drug for TBI and to determine effective dosing.  Upon completion of this stage, we will embark on IND enabling studies, Toxicology, Pharmacokinetics, Pharmacodynamics, ADME (absorption, distribution, metabolism, and excretion), and CMC (chemistry, manufacturing, and control).  We are working with a premier FDA consulting company who will ensure that our pre-clinical and IND enabling studies are in line with FDA requirements and will assist us in preparing our IND package for submission to the FDA.  Upon FDA acceptance of our IND, we will initiate our human clinical trials in collaboration with the University of Miami and possibly other TBI centers of excellence.

Q: Investorideas.com
Can you talk about your 35 years of experience in development and commercialization of products in the pharmaceutical industry?

 A: Maghsoud Dariani, Chief Scientific Officer

Excellent question.  What I have learned during my drug development and commercialization journey is that success requires i) being meticulous and completely thorough during pre-clinical evaluation of drugs under development and ii) paying attention to what the data is telling you during early stages of clinical trials.  Pre-clinical pharmacodynamics is relatively inexpensive and can save a lot of money by preventing the wrong compounds from going forward.  The compounds should be evaluated in as many validated models as possible to ensure both efficacy and safety.  Rushing through this stage and cutting corners can result in costly future failures. Once the compounds have successfully passed through pre-clinical development, careful attention to and thorough analyses of the outcomes from phase I and II clinical trials are critical.  Often, companies and people are under pressure to move compounds to phase III pivotal trials, which are very costly and time consuming.  Failure to do adequate early analyses and ignoring what the data is saying results in disappointing and very costly failures in meeting phase III clinical end points.

Q: Investorideas.com
Do you see  taking a different path or strategy for a smaller  company like Scythian Biosciences  versus  working with a larger company like Celgene Corporation  (NASDAQ: CELG) ?


A: Maghsoud Dariani, Chief Scientific Officer
Fundamentally speaking, NO.  Drug development has distinct stages which have to be followed whether you are a small company or a large one.  The only differences that I see, is that smaller companies are much less bureaucratic and there are a lot less layers.  This simply translates to faster decisions and a somewhat shorter timeline to commercialization.

Q: Investorideas.com
Can you talk about what is unique about the company’s drug (s) in development?

A: Maghsoud Dariani, Chief Scientific Officer

There is currently no approved drug for mild traumatic brain injury and concussion which afflicts more than 2 million mostly young people in the US.  Trauma causes inflammation followed by immune response (gliosis) that can damage nerve cells.  Depending on the severity of the trauma, the resulting symptoms can last for several months or stay with injured people for the rest of their lives. Early and successful drug intervention to reduce inflammation and reduce gliosis is urgently needed.  Our drug under development is a combination of two compounds that attack neuronal inflammation and gliosis through two different pathways.  This is a unique and proprietary approach that has not been tried before.   

Q: Investorideas.com
How do you see Cannabinoids playing a role in the future of pharma and biotech?

A: Maghsoud Dariani, Chief Scientific Officer

The cannabinoid system is present throughout the central nervous system and is crucial for controlling a range neurophysiological processes such as pain, appetite, learning and memory.  The cannabinoid receptors, CB1 and CB2 in the central nervous system are also targets for cannabinoids isolated from the cannabis plant (marijuana) as well as their synthetic analogues. The cannabinoid system has emerged as a key regulator of neuronal cell fate and is seen as capable of conferring neuroprotection.  Many neurological diseases have neurodegenerative components that result from neuroinflammation, oxidative stress and excitotoxicity.  Natural and synthetic cannabinoids represent a class of compounds that are attractive for the development of neurodegenerative diseases such as epilepsy, Tourette’s syndrome, multiple sclerosis, pain, schizophrenia, Alzheimer's disease and cerebral ischemia.

Q: Investorideas.com
In closing on a personal note, what motivated and inspired you to come on board as Chief Scientific Officer of Scythian?

A: Maghsoud Dariani, Chief Scientific Officer

I love challenges and developing a potential treatment for concussion and/or mild traumatic brain injury is a big challenge!  It is a condition with unmet need that afflicts significant number of people.  I also have an excellent track record in overseeing and managing R&D, and when Jonathan asked me to join his team, it was a great fit and I accepted it with enthusiasm.

About Mr. Dariani

Mr. Dariani has over 35 years of diverse and progressive management experience in the development and commercialization of products in the pharmaceutical industry. Mr. Dariani has a successful record of business management, strategic planning, acquisition and divestiture, project management, production management, R&D management, economic evaluations, competitor analyses, and development and administration of multi-million dollar budgets. Mr. Dariani is an entrepreneurial business leader with a sound grasp of successful business strategies, an excellent foundation in science and engineering, and a strong background in product development and commercialization. He is currently the CEO of Semorex Inc. – a privately held company focused on the discovery and development of novel therapeutics for cancer. Mr. Dariani also leads Myos Rens' science and technology efforts and has overall responsibilities for manufacturing, basic science, pre-clinical and clinical studies. Prior to joining Semorex Inc., Mr. Dariani was President of Focus Pharmaceuticals, Inc ("Focus") where he managed the development and approval of drug products, achieving one FDA approval and bringing another to the clinical evaluation stage. Prior to joining Focus, Mr. Dariani was Vice President of the chiral pharmaceutical business unit at Celgene Corporation ("Celgene"). During his twelve years at Celgene, Mr. Dariani developed and implemented Celgene's manufacturing strategy, managed and successfully sold Celgene's chiral intermediates business unit, and formulated a strategic plan for leveraging Celgene's expertise in chiral technologies towards the development of chirally pure drug products. Mr. Dariani was responsible for the successful development and FDA approval of the chirally pure versions of Ritalin, which are currently marketed by Novartis under the Focalin and Focalin XR trade names. Prior to Celgene, Mr. Dariani held progressively more responsible engineering and development positions at Celanese Corporation. Mr. Dariani holds a Bachelor of Science from The City College of New York and a Master of Science from University of Massachusetts in Chemical Engineering. Mr. Dariani is a member of Board of Directors at Semorex Inc. and Mesa Therapeutics.

Description:
Maghsoud Dariani, Chief Scientific Officer Scythian Biosciences Corp. (TSXV: SCYB)

Scythian is a research and development company committed to finding a solution for the prevention and treatment of concussions and traumatic brain injury with its proprietary Cannabinoid combination.

Scythian's mission is to be the first accepted drug regimen for concussive treatment. Scythian has recently formed a collaboration with the University of Miami and its world renowned neuroscientific team to conduct pre-clinical and clinical trials of its drug regimen. The University of Miami believes that Scythian's scientific approach shows significant promise and differs from previous approaches to treat this growing problem. The collaboration with the University of Miami allows access to their extensive knowledge base in the fields of traumatic brain injury and concussions and allows for Scythian's clinical studies to be undertaken at their world-class facilities

Gillian A. Hotz, PhD, is leading Scythian's program at the University of Miami. Dr. Hotz is a nationally recognized behavioral neuroscientist and expert in neurotrauma, concussion management, and neurorehabilitation. She has extensive experience in neurocognitive testing. Dr. Hotz has been the co-director of University of Miami Miller School of Medicine's Concussion Program since 1995.

Scythian is also endorsed by Pro Football Legends and the World Boxing Association on its mission.

Subscribe to our cannabis news RSS feed: http://www.investorideas.com/rss/feeds/portals/marijuana.xml

For a full list of marijuana and cannabis stocks visit:

About Investorideas.com - News that Inspires Big Ideas
Investorideas.com is a meeting place for global investors, featuring news, stock directories, video, company profiles, interviews and more in leading sectors.   Investorideas.com cannabis/marijuana and hemp content now includes http://cannabisstocknews.blogspot.com on Blogger.com: the Investorideas.com news and stock directory pages, a cannabis investor group on Linkedin.com, The 420 Cannabis Investor ideas www.420cannabisinvestorideas.com and the new AI site  Global Cannabis Investing at www.Globalcannabisinvesting.com.


Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Scythian Biosciences Corp. (SCYB) is a paid featured company on the 420 Cannabis Investor Ideas Directory and is a paid featured Cannabis Company and biotech for news, social media and PR effective August 7th for 2 months. More details - http://www.investorideas.com/About/News/Clientspecifics.asp

Visit the Scythian Biosciences (TSX.V: SCYB) Profile page: http://www.investorideas.com/CO/SCYB/

Contact Investorideas.com

800-665-0411

Patriot One Technologies Inc. (TSX.V: $PAT.V) (OTCQB: $PTOTF) at the Extraordinary Future 2017 Conference

Patriot One Technologies Inc. (TSX.V:  $PAT.V) (OTCQB: $PTOTF)  at the Extraordinary Future 2017 Conference


Point Roberts, WA, Delta BC – September 25, 2017 – Investorideas.com, a global news source and investor resource covering actively traded sectors including tech stocks , visits the Extraordinary Future 2017 conference held at  the  Vancouver Convention Centre East Vancouver September 20, 2017.

The conference was created to unite and inspire Vancouver’s entrepreneur, finance, technology and influencer communities with exceptional, future thinking content.

Patriot One Technologies Inc. (TSX.V: PAT) (OTCQB: PTOTF) is looking toward market rollout for their award-winning PATSCAN CMR (Cognitive Microwave Radar) concealed weapons technology according to company CEO Martin Cronin.

Cronin spoke at the Extraordinary Future Conference, where he confirmed Industry Canada certification for PATSCAN CMR. Cronin said that because regulations are so similar between IC and the U.S. equivalent FCC, that the company is confident in receiving certification in America soon.

“We’ve just had news on our Canadian certification being through, which is great news,” he said. “The Canadian regulations are identical to the U.S. regulations and so everything’s been submitted to FCC, so we’re hopeful that we’ll have that certification through shortly, and we’re now looking at our commercial rollout.”

PATSCAN CMR concealed weapons technology is a detection system designed to combat active shooter threats before they occur. Cronin said the company’s commercial rollout for PATSCAN CMR will rely on securing a few significant clients initially before wider marketing can take place.

“When we go to market with this we’re going to have a very careful strategy of getting some early adopter high profile clients, then we can really overengineer the installation,” he said. “This is machine intelligence where it learns its environment. We’re going to make sure we don’t just go for a mass market and fall over and have failures. We’re out making sure we engineer the conditions for success.”

Samuel Mowers for Investorideas.com


About Extraordinary Future 2017

A journey through the technologies that will directly impact the course of our lives: The extraordinary future of science and life.

Mission: Unite and inspire Vancouver’s entrepreneur, finance, technology and influencer communities with exceptional, future thinking content
Promote and showcase Canada’s technology industry
Connect technology companies with the Vancouver financing and investment community

The Extraordinary Future Conference hosted world class speakers and companies focusing on:

Artificial Intelligence
Virtual and Augmented Reality
Space Exploration
Energy in the 21st Century
Blockchain Technology
The Future of Health
Technology and Finance


About Investorideas.com - News that Inspires Big Ideas
www.Investorideas.com  is a meeting place for global investors, featuring news, stock directories, video, podcasts, company profiles, interviews and more in leading sectors.

Sectors we cover include tech, bitcoin and blockchain, biotech, mining, energy, renewable energy, water stocks, marijuana and hemp stocks, food and beverage (including organic and LOHAS, wine), defense and security (including biometrics), Latin America, sports, entertainment, luxury brands and gaming.

The Investorideas.com content portfolio goes beyond the www.investorideas.com site to include 14 blogs on Blogger.com, 7 Artificial Intelligence (AI) websites on the Grid and the Waternewswire.com, all featuring Investorideas.com news and content.

Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas



This news is published on the Investorideas.com Newswire – News that Inspires big ideas Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. Disclosure Patriot One Technologies Inc., (TSX.V: PAT) (OTCQB: PTOTF) is an ongoing client of the Investorideas newswire .Learn more about costs and our newswire service http://www.investorideas.com/News-Upload/


Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Contact Investorideas.com
800-665-0411



Description: TechSectorStocks.com - Leading Investor Research for Technology Stocks

TechSectorStocks.com - investing ideas in tech stocks - mobile payments, social media, AI and Robotics, Drone Stocks, GPS, Internet of Things (IoT)



Thursday, September 21, 2017

Canadian Listed Cannabis Stock News Highlights; (TSX: $ACB. TO) (TSX: $CMED.TO) (TSX: $LEAF.TO), (TSXV: $SCYB.V)

Canadian Listed Cannabis Stock News Highlights; (TSX: $ACB. TO) (TSX: $CMED.TO) (TSX: $LEAF.TO), (TSXV: $SCYB.V)



September 21, 2017 – Investorideas.com, a global news source and investor resource covering cannabis stocks releases recent news highlights from some of the top Canadian listed cannabis companies.



Subscribe to our cannabis news RSS feed:http://www.investorideas.com/rss/feeds/portals/marijuana.xml

For a full list of marijuana and cannabis stocks visit:

About Investorideas.com - News that Inspires Big Ideas
Investorideas.com is a meeting place for global investors, featuring news, stock directories, video, company profiles, interviews and more in leading sectors.  Investorideas.com cannabis/marijuana and hemp content now includeshttp://cannabisstocknews.blogspot.com on Blogger.com: the Investorideas.com news and stock directory pages, a cannabis investor group on Linkedin.com, The 420 Cannabis Investor ideas www.420cannabisinvestorideas.com and the new AI site  Global Cannabis Investing at www.Globalcannabisinvesting.com.


Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info:http://www.investorideas.com/About/Disclaimer.asp.
Scythian Biosciences Corp. (SCYB) is a paid featured company on the 420 Cannabis Investor Ideas Directory and is a paid featured Cannabis Company and biotech for news, social media and PR effective August 7th for 2 months. More details -http://www.investorideas.com/About/News/Clientspecifics.asp

Visit the Scythian Biosciences (TSX.V: SCYBProfile page:http://www.investorideas.com/CO/SCYB/

Contact Investorideas.com

800-665-0411

Podcast Corner at Investorideas.com with the CTO of Stockpile



Podcast Corner at Investorideas.com with the CTO of Stockpile

“Our goal is to bring everyone into the stock market and enable financial literacy for the younger demographic”



September 21, 2017 - Investorideas.com, a global news source and investor resource releases an exclusive podcast interview with the CTO of Stockpile.

Online brokerage firm Stockpile aims to invest in the education and encouragement of the next generation of investors according to the company’s Chief Technology Officer, Namrata Ganatra.

“Our goal is to bring everyone into the stock market and enable financial literacy for the younger demographic,” she said.

Listen to the full podcast:


About Investorideas.com - News that Inspires Big Ideas
www.Investorideas.com  is a meeting place for global investors, featuring news, stock directories, video, podcasts, company profiles, interviews and more in leading sectors.

The Investorideas.com podcasts are also available on iTunes, Tunein, Stitcher. Spreaker.com, iHeart.com and Google Play Music.
Visit the Podcast page at Investorideas.com: http://www.investorideas.com/Audio/

Subscribe to Investorideas.com Podcast RSS:

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.

Contact Investorideas.com
800-665-0411




Wednesday, September 20, 2017

Investorideas.com adds to Content Portfolio with Cannabisinvestorideas.com and Cryptocurrencyinvestorideas.com

Investorideas.com adds to Content Portfolio with Cannabisinvestorideas.com and Cryptocurrencyinvestorideas.com


September 20, 2017 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana/hemp stocks and blockchain/cryptocurrency stocks announces it has expanded its content portfolio to include http://www.cannabisinvestorideas.com and http://www.cryptocurrencyinvestorideas.com/  all within the Investorideas.com hub.

Content on CryptocurrencyInvestorideas.com features news, podcasts, videos, articles and a stock directory featuring Bitcoin, Blockchain and Digital Currency Stocks and ICO's.
Content onCannabisinvestorideas.com includes news, articles, videos and interviews as well as a comprehensive stock directory.

Investorideas.com cannabis/marijuana and hemp content also includes podcasts with experts in the  sector, its blog http://cannabisstocknews.blogspot.com on Blogger.com: the Investorideas.com news and stock directory pages, a cannabis investor group on Linkedin.com , the 420 Cannabis Investor ideas www.420cannabisinvestorideas.com, and the AI site Global Cannabis Investing at www.Globalcannabisinvesting.com


About Investorideas.com - News that Inspires Big Ideas
Investorideas.com is a meeting place for global investors, featuring news, stock directories, video, company profiles, interviews and more in leading sectors.   
www.Investorideas.com  is a meeting place for global investors, featuring news, stock directories, video, podcasts, company profiles, interviews and more in leading sectors.

Sectors we cover include tech, bitcoin and blockchain, biotech, mining, energy, renewable energy, water stocks, marijuana and hemp stocks, food and beverage (including organic and LOHAS, wine), defense and security (including biometrics), Latin America, sports, entertainment, luxury brands and gaming.

The Investorideas.com content portfolio goes beyond the www.investorideas.com site to include 14 blogs on Blogger.com, 7 Artificial Intelligence (AI) websites on the Grid and the Waternewswire.com, all featuring Investorideas.com news and content.

Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas

Investor Ideas Directories for global investors:
From water stocks to gold and mining stocks, renewable energy, nanotech, defense, technology, biotech and more – use our stock directories and access them online 24/7 with login as a member to find your next big idea!

Services for Publicly traded companies: http://www.investorideas.com/Investors/Services.asp

Investorideas.com CSE service provider directory listing: http://thecse.com/en/services/services-for-listed-companies

Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas

Disclaimer: This directory is not a recommendation to buy or sell securities or products or services Investorideas.com charges a fee for placement. The directory is not an endorsement or recommendation but meant to be an investor resource/ due diligence tool.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.  Global investors must adhere to regulations of each country.

Contact Investorideas.com
800-665-0411




#IoT Company #Trakopolis (TSXV: $TRAK.V) Wins New Enterprise Customer for its ELD Offering ; @trakopolis

#IoT Company #Trakopolis (TSXV: $TRAK.V) Wins  New Enterprise Customer for its ELD Offering  ; @trakopolis

Number of active ELD subscriptions now 332 with the potential for an additional 750 from initial customers




Calgary, Alberta - September 20, 2017 (Investorideas.com Newswire) #IoT Stock News -Trakopolis IoT Corp. (TSXV: TRAK) reports  on strong sales results of its recently launched (Electronic Logging Device) ELD product.

The Company has won a new enterprise customer for its ELD offering bringing the number of active ELD subscriptions to 332 with the potential for an additional 750 from initial customers. Active pilot projects represent further opportunities in excess of 600 ELD units.


Watch our ELD Solutions Video Here: https://www.youtube.com/watch?v=js7-2oaNNZs



About the ELD Mandate
Another key driver of growth for the telematics industry overall is the incoming electronic logbook requirements. This is a result of the U.S. FMCSA’s (Federal Motor Carrier Safety Administration) new rules aimed at improving the safety of commercial truck and bus drivers. The rule requires drivers to install and use electronic logging devices (moving away from paper records) to ensure the compliance with hours-of-service regulations. The new rule will go into effect in December 2017 and will be implemented in phases over the following two years. Canada is expected to follow with similar regulations. To enhance its offering in this area, Trakopolis purchased the electronic logbook software assets of Verigo in November 2016. Trakopolis is now able to offer its growing customer base a solution to address these regulations.

About Trakopolis
Trakopolis is a Software as a Service (SaaS) company with proprietary, cloud-based solutions for real-time tracking, data analysis and management of corporate assets such as equipment, devices, vehicles and personnel. The Company’s asset management platform works across a variety of networks and devices. Trakopolis has a diversified revenue stream from many verticals including oil and gas, forestry, transportation, construction, rentals, urban services, mining, government and others.

This news is published on the Investorideas.com Newswire – News that Inspires big ideas

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. Disclosure this news is a paid for news release on the Investorideas.com newswire for Trakopolis IoT Corp. (TSXV: TRAK). Learn more about costs and our newswire service http://www.investorideas.com/News-Upload/

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.